Skip to main content
PTHL logo
PTHL
(NASDAQ)
iTonic Holdings Ltd.
$0.31-- (--)
Loading... - Market loading

iTonic Holdings (PTHL) Company Profile

Complete business overview, executive team, trading details, and corporate information.

iTonic Holdings Ltd.
PTHLNASDAQHealthcareMedical Devices

About iTonic Holdings

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

Company Information

CEOJianfei Zhang
Founded1998
IPO DateSeptember 5, 2024
Employees10
CountryChina
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
Share ClassClass A Shares

Contact Information

Phone86 10 8481 7665
Address
NET Building, Room 306 Beijing, 100101 China

Corporate Identifiers

CIK0001970544
ISINKYG713991027
SIC3845

Leadership Team & Key Executives

Jianfei Zhang
Chief Executive Officer and Chairman of the Board
Zhixin Li
Chief Financial Officer